期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Downregulation of Scar Fibroblasts by Antineoplastic Drugs: A Potential Treatment for Fibroproliferative Disorders
1
作者 M. Georgina Uberti Yvonne N. Pierpont +3 位作者 Rajat Bhalla Karan Desai Martin C. Robson Wyatt G. Payne 《Surgical Science》 2016年第6期258-271,共14页
The various fibroproliferative disorders affecting humans have in common excess fibroblast activity and persistent overexpression or dysregulated activity of transforming growth factor beta (TGF-β). Cancer has many s... The various fibroproliferative disorders affecting humans have in common excess fibroblast activity and persistent overexpression or dysregulated activity of transforming growth factor beta (TGF-β). Cancer has many similar characteristics. Antineoplastic drugs can downregulate fibroblast activity and cytokine growth factors. This study evaluates the effect of six antineoplastic drugs on keloid and Dupuytren’s disease fibroblasts. Keloid, normal scar, Dupuytren’s affected palmar fascia, and normal palmar fascia fibroblasts were grown and seeded into Fibroblast Populated Collagen Lattices (FPCLs). The FPCLs were treated with one of six antineoplastic drugs or left untreated as controls. At 7 days, supernatants were extracted from all FPCLs and assayed for expression of Transforming Growth Factor beta (TGF)-β<sub>1</sub> and TGF-β<sub>2</sub>. All six antineoplastic drugs significantly inhibited FPCL contraction in both fibroproliferative conditions compared with the untreated controls (p β<sub>1</sub> and TGF-β<sub>2</sub> expression was downregulated in the supernatants of all FPCLs by the drug exposure. Cytotoxicity did not occur in these studies and was not the reason for the results. Although antineoplastic drugs can have significant side effects when given systemically, these results may be minimized when given to small areas involved in fibroproliferative scarring or when given topically or intralesionally. These in vitro results suggest that antineoplastic drugs may have a utility for treating various fibroproliferative disorders and warrant further investigation. 展开更多
关键词 scar fibroblasts Antineoplastic Drugs Fibroproliferative Disorders Dupuytren’s Disease KELOID
下载PDF
Effect of TGF-β1 on expression of β-catenin in fibroblasts of pathological scar and its significance
2
作者 肖明 《外科研究与新技术》 2011年第4期272-272,共1页
Objective To explore interaction and interrelationship between TGF - β/Smad signal pathway and Wnt/β - catenin signal pathway in pathogenesis of pathological scar. Methods Three cases of keloid ( K group) ,3 of hype... Objective To explore interaction and interrelationship between TGF - β/Smad signal pathway and Wnt/β - catenin signal pathway in pathogenesis of pathological scar. Methods Three cases of keloid ( K group) ,3 of hyperplastic scar ( H group) and 3 of normal skin ( N group) were selected randomly, and then 展开更多
关键词 Effect of TGF catenin in fibroblasts of pathological scar and its significance on expression of
下载PDF
The expression of Cyclin A and p21^(cip1)in fibroblast of hypertrophic scar
3
作者 金文虎 《外科研究与新技术》 2011年第2期131-131,共1页
Objective To study the relation of the mRNA and protein expression of CyclinA and p21cip1 in different stages hypertrophic scar fibroblast (FB) with its cell cycle,so as to provide theoretical evidence for interventio... Objective To study the relation of the mRNA and protein expression of CyclinA and p21cip1 in different stages hypertrophic scar fibroblast (FB) with its cell cycle,so as to provide theoretical evidence for intervention therapy of 展开更多
关键词 MRNA cip1)in fibroblast of hypertrophic scar The expression of Cyclin A and p21
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部